Phenylephrine 2.5% ophthalmic solution (PE): Clinical Trials

1 trial of Phenylephrine 2.5% ophthalmic solution (PE), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Phenylephrine 2.5% ophthalmic solution (PE): new trials by email Literature Review of Phenylephrine 2.5% ophthalmic solution (PE) trials Research Report on Phenylephrine 2.5% ophthalmic solution (PE)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation
Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE), Tropicamide 1% ophthalmic solution (TR), Phenylephrine 2.5% ophthalmic solution (PE) - Mydriasis
Phase 3CompletedEyenovia Inc.702018-11-152022-03-18

Conditions studied

Mydriasis (1)

Sponsors

Eyenovia Inc. (1)

Countries

United States (1)

Top investigators

Tsontcho Ianchulev, MD, MPH (1)